Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Merge with TPL is a good thing? All
6
May 08, 2008 10:07AM
4
May 08, 2008 10:46AM
2
May 08, 2008 11:04AM
3
May 08, 2008 12:10PM
3
May 08, 2008 01:01PM
1
May 09, 2008 03:45AM
2
May 09, 2008 06:02AM

Wouldn't a merger with TPL be a good thing if the company would remain public?

TPL has no shares so if they join with PTSC there would be no additional share count added.

By joining with PTSC 100% of the revenue collected from the MMP would double the amount of revenue reported in the Q's. This would be a benefit to us if we are valued on the MMP's worth. Instead of being valued at 50% of the MMP we would be valued at 100% of the MMP.

TPL appears to be well managed and is a growing company.

TPL's leaders and legal team appear to be much stronger than PTSC's.

TPL would clean out the dead wood on the PTSC BOD.

Unless I'm missing something to me a merger would be great as long as they keep the company public.

So what am I missing?

All the best,

Steve

Share
New Message
Please login to post a reply